Craig Rosen, Ph.D., Biopharmaceutical Development Expert, Joins Phase Bioscience, Inc. as Executive Chairman
10/9/2008 9:30:55 AM
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Says to Acquire CoGenesys, Inc. for $400 Million
1/22/2008 6:51:38 AM
More...
|
Vegenics Limited Licenses From CoGenesys, Inc. Antibodies Against VEGF-C for Applications Including Oncology
6/18/2007 10:40:05 AM
More...
|
CoGenesys, Inc. Announces the Achievement of Milestones Under License Agreements With PDL BioPharma, Inc. (PDLI) and Vegenics Limited
5/23/2007 12:30:40 PM
More...
|
CoGenesys, Inc. Expands Clinical Programs with Initiation of Phase 1-2a Trial of Neugranin in Cancer Patients
3/27/2007 11:10:21 AM
More...
|
The Day In Review: Two Big Deals To Start The New Year
1/3/2007 6:32:13 PM
More...
|
CoGenesys, Inc. Files To Begin Clinical Trials Of Neugranin For The Prevention Of Infections In Cancer Patients
1/3/2007 2:03:42 PM
More...
|
Dr. David U'Prichard Joins CoGenesys, Inc. Board Of Directors
12/19/2006 10:10:01 AM
More...
|
CoGenesys, Inc. Initiates Phase 1-2 Clinical Trial Of Cardeva In Patients With Heart Failure
10/11/2006 10:33:18 AM
More...
|
CoGenesys, Inc. Announces Worldwide License Agreement With Vegenics Limited
8/21/2006 8:01:57 AM
More...
|
|